CTOs on the Move

Hydrogen Advertising

www.hydrogenadvertising.com

 
Hydrogen Advertising is a Seattle, WA-based company in the Business Services sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

American Civil Liberties Union of Mississippi

American Civil Liberties Union of Mississippi is a Jackson, MS-based company in the Business Services sector.

Yunker Industries Inc.

Yunker Industries Inc. is one of the leading providers in Business Services. It is based in Lake Geneva, WI. To find more information about Yunker Industries Inc., please visit www.yunker.com.

Dunshee House At Face Rock

Dunshee House At Face Rock is a Bandon, OR-based company in the Business Services sector.

Highland Precision Plating Inc

Highland Precision Plating Inc is a Hillsboro, OH-based company in the Business Services sector.

enGene

At enGene, we are at the vanguard of a new era in genetic medicine: Our novel Dually Derivatized Oligochitosan® (DDX) gene delivery platform is designed to enable localized delivery of multiple gene cargos, including RNA and DNA, directly to mucosal tissues and other organs — potentially overcoming the limitations of viral-based gene therapies and advancing gene therapy beyond rare genetic diseases into the mainstream of clinical practice. Our breakthrough Dually Derivatized Oligochitosan® (DDX) platform opens possibilities for streamlining the use of genetic medicines in the treatment of serious diseases, especially diseases afflicting mucosal tissues. Our lead product candidate, EG-70 (detalimogene voraplasmid), is a non-viral immunotherapy in development to treat non-muscle invasive bladder cancer (NMIBC), a disease with a significant patient burden, high clinical needs, and massive healthcare system economic impact. Based on its preliminary efficacy and safety profile and ease of administration by urologists, EG-70, which is currently in a pivotal trial, can potentially benefit patients across a wide variety of clinical settings. As enGeneers, we are boldly focused on patients needs. We are a team of passionate experts with extensive experience in drug development and commercialization across oncology, respiratory, and several other therapeutic areas. Nasdaq: ENGN